MARKET

AQST

AQST

Aquestive Therapeutics
NASDAQ
4.295
-0.035
-0.81%
Opening 15:01 07/08 EDT
OPEN
4.260
PREV CLOSE
4.330
HIGH
4.340
LOW
4.235
VOLUME
707.39K
TURNOVER
--
52 WEEK HIGH
7.55
52 WEEK LOW
2.930
MARKET CAP
538.81M
P/E (TTM)
-7.1263
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AQST last week (0629-0703)?
Weekly Report · 2d ago
Weekly Report: what happened at AQST last week (0622-0626)?
Weekly Report · 06/29 10:22
Aquestive Therapeutics files to sell 230,271 shares of common stock for holders
TipRanks · 06/26 20:25
Aquestive Therapeutics Files Prospectus For Offering 230,271 Common Shares On Behalf Of Selling Shareholders
Benzinga · 06/26 20:23
AQUESTIVE THERAPEUTICS - FILES PROSPECTUS FOR RESALE OF UP TO 230,271 COMMON SHARES BY THE SELLING STOCKHOLDERS - SEC FILING
Reuters · 06/26 20:22
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)
TipRanks · 06/26 12:30
BTIG’s Brisebois Reiterates Buy on Aquestive Therapeutics, Calling Sell-Off Overdone After SPRY Payer Update and Highlighting Limited Scope of FDA CRL for Anaphylm
TipRanks · 06/25 16:55
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST), Revolution Medicines (RVMD) and Bolt Biotherapeutics (BOLT)
TipRanks · 06/25 12:00
More
About AQST
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in developing orally administered and topical gel products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. It has four commercialized products marketed by the Company’s licensees in the United States and around the world and is the manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary technologies, including PharmFilm, and has proven drug development and commercialization capabilities. The Company is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel product candidate for various possible dermatology conditions. Its portfolio includes Anaphylm, AQST-108, Libervant, Suboxone, and Emylif.

Webull offers Aquestive Therapeutics Inc stock information, including NASDAQ: AQST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AQST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AQST stock methods without spending real money on the virtual paper trading platform.